Stereotaxis, Inc. (STXS) Stock Analysis & Investment Frameworks
Stereotaxis, Inc. (STXS) stock analysis on Invetso. Review Stereotaxis, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Stereotaxis, Inc. Company Overview
- Exchange: New York Stock Exchange Arca
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
Stereotaxis, Inc. Key Financial Metrics
- Market Cap: $101.20M
- Revenue: $32.38M
- ROE: -132.62%
- ROIC: -74.49%
- Dividend Yield: N/A
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Stereotaxis, Inc. Investment Frameworks
Invetso analyzes Stereotaxis, Inc. (STXS) across the following frameworks:
- Stereotaxis, Inc. 10Y Growth Potential
- Stereotaxis, Inc. Scenario Analysis
- Stereotaxis, Inc. Risks & Opportunities
- Stereotaxis, Inc. Economic Moat
- Stereotaxis, Inc. Business Model
- Stereotaxis, Inc. Management
- Stereotaxis, Inc. SWOT Analysis
- Stereotaxis, Inc. Porter's 5 Forces
- Stereotaxis, Inc. PESTLE Analysis
- Stereotaxis, Inc. ESG Analysis